镰状细胞病长期生存的心肺血流动力学决定因素:ETENDARD研究
基于法国ETENDARD队列398例镰状细胞病患者,所有参与者接受超声心动图,三尖瓣反流速度≥2.5 m/s者行右心导管检查,随访至少10年。平均肺动脉压>20 mm Hg者44例(11%),肺血管阻力≥1.5 Wood单位且平均肺动脉压>20 mm Hg者死亡调整风险比为4.27(95%CI 1.88-9.74;P<0.001)。
要点
- 平均肺动脉压>20 mm Hg者占11%,其中肺毛细血管楔压≤15 mm Hg者占6.5%。
- 肺血管阻力阈值1.5 Wood单位可预测平均肺动脉压>20 mm Hg患者的死亡风险。
- 溶血表型及系统性并发症与肺血管阻力升高和死亡风险增加相关。
核心结论
- 肺血管阻力阈值1.5 Wood单位是平均肺动脉压>20 mm Hg镰状细胞病患者死亡的关键预测因素。
- 结合溶血标志物和系统性并发症评估时,肺血管阻力的预后价值更显著。
研究设计与样本
- 法国ETENDARD队列分析,共398例镰状细胞病患者。
- 所有参与者接受超声心动图,三尖瓣反流速度≥2.5 m/s者行右心导管检查。
- 随访至少10年,评估血流动力学变量的临床和预后意义。
主要发现
- 平均肺动脉压>20 mm Hg者44例(11%),其中肺毛细血管楔压≤15 mm Hg者26例(6.5%),>15 mm Hg者18例(4.5%)。
- 随访期间死亡率为11.1%。
- 肺血管阻力与死亡风险显著相关,受体操作特征曲线分析确定阈值为1.5 Wood单位。
- 平均肺动脉压>20 mm Hg且肺血管阻力≥1.5 Wood单位者死亡调整风险比为4.27(95%CI 1.88-9.74;P<0.001)。
- 溶血表型及系统性并发症(包括高血压、左心室舒张功能障碍、肾功能损害和腿部溃疡)与肺血管阻力升高和死亡风险增加相关。
关键数值与推荐
- 肺动脉高压定义为平均肺动脉压>20 mm Hg。
- 肺血管阻力阈值1.5 Wood单位通过受体操作特征曲线分析确定。
- 平均肺动脉压>20 mm Hg且肺血管阻力≥1.5 Wood单位者死亡调整风险比4.27(95%CI 1.88-9.74;P<0.001)。
临床怎么用
- 对镰状细胞病患者应评估平均肺动脉压和肺血管阻力,肺血管阻力≥1.5 Wood单位提示死亡风险增加。
- 结合溶血标志物和系统性并发症(高血压、左心室舒张功能障碍、肾功能损害、腿部溃疡)综合评估预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Pulmonary hypertension is a serious cardiopulmonary complication of sickle cell disease, but the prognostic impact of hemodynamic parameters remains poorly defined. Objectives: This study aimed to assess the clinical and long-term prognostic relevance of hemodynamic parameters in sickle cell disease. Methods: Data were analyzed from the French ETENDARD cohort. All 398 participants underwent echocardiography; those with tricuspid regurgitation velocity ⩾2.5 m/s proceeded to right heart catheterization. Over a minimum 10-year follow-up, we examined the clinical and prognostic significance of hemodynamic variables. Measurements and Main Results: Pulmonary hypertension defined by a mean pulmonary arterial pressure (mPAP) >20 mm Hg was identified in 44 patients (11%). Among them, 26 (6.5%) had a pulmonary arterial wedge pressure ⩽15 mm Hg, and 18 (4.5%) had a pulmonary arterial wedge pressure >15 mm Hg. Mortality during follow-up was 11.1%. A significant association was found between pulmonary vascular resistance (PVR) levels and mortality risk, with a threshold identified at 1.5 Wood units (WU) through receiver operating characteristic curve analyses. In patients with mPAP >20 mm Hg and PVR ⩾1.5 WU, the adjusted hazard ratio for mortality was 4.27 (95% confidence interval, 1.88-9.74; P < 0.001). A hemolytic phenotype and the presence of systemic complications, including hypertension, left ventricular diastolic dysfunction, renal impairment, and leg ulcers, were associated with elevated PVR and increased mortality risk. Conclusions: A PVR threshold of 1.5 WU emerges as a key predictor of mortality in patients with an mPAP above 20 mm Hg, particularly when assessed in conjunction with markers of hemolysis and systemic complications.
引用
- Savale L, d'Humières T, Boucly A, et al. Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study. Am J Respir Crit Care Med. 2025. PMID: 40938591. doi:10.1164/rccm.202502-0353OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。